Skip to main content
. Author manuscript; available in PMC: 2014 Nov 1.
Published in final edited form as: Br J Haematol. 2013 Sep 6;163(3):10.1111/bjh.12542. doi: 10.1111/bjh.12542

Figure 1. Patient characteristics.

Figure 1

A. Numbers of patients in each treatment group stratified by normal lactate dehydrogenase (NL LDH; < 2x upper limit of normal [ULN]) or high LDH (HI LDH; > 2x ULN) initial LDH levels. B. Incidence of increased LDH by treatment group. C. Incidence of Group C treatment group stratified by bone marrow only [B-ALL (CNS−)], central nervous system (CNS) only and combined [B-ALL (CNS+)].